MDM2 and liposarcoma: Romidepsin is one example, which showed efficacy in dedifferentiated liposarcoma through suppression of (MDM2) expression and cell death enhancement [47,48], and Valproate is another inhibitor, which demonstrated some response in endometrial stromal sarcoma [49].